Search Results - "Schlaeppi, Jean‐Marc"

Refine Results
  1. 1
  2. 2

    Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection by Lavoisier, Alexandra, Schlaeppi, Jean-Marc

    Published in mAbs (01-01-2015)
    “…Therapeutic antibodies represent one of the fastest growing segments in the pharmaceutical market. They are used in a broad range of disease fields, such as…”
    Get full text
    Journal Article
  3. 3

    Therapies directed at vascular endothelial growth factor by Manley, Paul W, Martiny-Baron, Georg, Schlaeppi, Jean-Marc, Wood, Jeanette M

    Published in Expert opinion on investigational drugs (01-12-2002)
    “…The inhibition of angiogenesis through vascular endothelial growth factor (VEGF) receptor targeting is a strategy that is relatively tumour selective. The high…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors by Schlaeppi, J M, Wood, J M

    Published in Cancer and metastasis reviews (1999)
    “…Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) is an important mediator of tumor-induced angiogenesis and represents a potential…”
    Get full text
    Journal Article
  6. 6

    X-Ray Structure of the hRORα LBD at 1.63 Å: Structural and Functional Data that Cholesterol or a Cholesterol Derivative Is the Natural Ligand of RORα by Kallen, Joerg A., Schlaeppi, Jean-Marc, Bitsch, Francis, Geisse, Sabine, Geiser, Martin, Delhon, Isabelle, Fournier, Brigitte

    Published in Structure (London) (01-12-2002)
    “…The retinoic acid-related orphan receptor α (RORα) is an orphan member of the subfamily 1 of nuclear hormone receptors. No X-ray structure of RORα has been…”
    Get full text
    Journal Article
  7. 7

    Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodies by Holenstein, Fabian, Eriksson, Christer, Erlandsson, Ioana, Norrman, Nils, Simon, Jill, Danielsson, Åke, Milicov, Adriana, Schindler, Patrick, Schlaeppi, Jean-Marc

    Published in Journal of Chromatography A (30-10-2015)
    “…•Automated pre-capture filtration of unclarified mammalian cell-culture broths.•Staggered and parallel unattended multi-step processing of eight 1-L feeds in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Crystal Structure of Human Estrogen-related Receptor α in Complex with a Synthetic Inverse Agonist Reveals Its Novel Molecular Mechanism by Kallen, Joerg, Lattmann, Rene, Beerli, Rene, Blechschmidt, Anke, Blommers, Marcel J.J., Geiser, Martin, Ottl, Johannes, Schlaeppi, Jean-Marc, Strauss, Andre, Fournier, Brigitte

    Published in The Journal of biological chemistry (10-08-2007)
    “…Inverse agonists of the constitutively active human estrogen-related receptorα (ERRα, NR3B1) are of potential interest for several disease indications (e.g…”
    Get full text
    Journal Article
  10. 10

    Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue by Chène, Patrick, Rudloff, Joëlle, Schoepfer, Joseph, Furet, Pascal, Meier, Peter, Qian, Zhiyan, Schlaeppi, Jean-Marc, Schmitz, Rita, Radimerski, Thomas

    Published in BMC chemical biology (07-01-2009)
    “…Topoisomerase II poisons are in clinical use as anti-cancer therapy for decades and work by stabilizing the enzyme-induced DNA breaks. In contrast, catalytic…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Identification of natural ligands of retinoic acid receptor-related orphan receptor α ligand-binding domain expressed in Sf9 cells––a mass spectrometry approach by Bitsch, Francis, Aichholz, Reiner, Kallen, Joerg, Geisse, Sabine, Fournier, Brigitte, Schlaeppi, Jean-Marc

    Published in Analytical biochemistry (01-12-2003)
    “…The ligand-binding domain (LBD) of the human retinoic acid receptor-related orphan receptor (RORα-LBD), expressed in Sf9 cells, was purified and analyzed by…”
    Get full text
    Journal Article
  13. 13

    Development of a Magnetic Particle-Based Automated Chemiluminescent Immunoassay for Triasulfuron by Schlaeppi, Jean-Marc A, Kessler, Anton, Foery, Werner

    Published in Journal of agricultural and food chemistry (01-09-1994)
    “…A fully automated immunoassay with high sample throughput for the quantitative analysis of triasulfuron in soil has been developed. The competitive assay was…”
    Get full text
    Journal Article
  14. 14

    A semi-automated large-scale process for the production of recombinant tagged proteins in the Baculovirus expression system by Schlaeppi, Jean-Marc, Henke, Mario, Mahnke, Marion, Hartmann, Steffen, Schmitz, Rita, Pouliquen, Yann, Kerins, Brendan, Weber, Eric, Kolbinger, Frank, Kocher, Hans P.

    Published in Protein expression and purification (01-12-2006)
    “…The efficient preparation of recombinant proteins at the lab-scale level is essential for drug discovery, in particular for structural biology, protein…”
    Get full text
    Journal Article
  15. 15

    Improved expression of kinases in Baculovirus-infected insect cells upon addition of specific kinase inhibitors to the culture helpful for structural studies by Strauss, André, Fendrich, Gabriele, Horisberger, Michel André, Liebetanz, Janis, Meyhack, Bernd, Schlaeppi, Jean-Marc, Schmitz, Rita

    Published in Protein expression and purification (01-12-2007)
    “…As exemplified by three cases, we show that the addition of a small molecular weight inhibitor to the culture of Baculovirus-infected insect cells can…”
    Get full text
    Journal Article
  16. 16

    1,25-DIHYDROXYVITAMIN D3 Induces the expression of vascular endothelial growth factor in osteoblastic cells by Schlaeppi, Jean-Marc, Gutzwiller, Sabine, Finkenzeller, Günter, Fournier, Brigitte

    Published in Endocrine research (1997)
    “…Angiogenesis is a fundamental process in skeletal development and repair, and previous studies indicate that vascular endothelial growth factor (VEGF), an…”
    Get full text
    Journal Article
  17. 17

    Hydroxyatrazine and atrazine determination in soil and water by enzyme-linked immunosorbent assay using specific monoclonal antibodies by Schlaeppi, Jean Marc, Foery, Werner, Ramsteiner, Klaus

    Published in Journal of agricultural and food chemistry (01-11-1989)
    “…An immunoassay was developed for atrazine and hydroxyatrazine. Hybridoma technology was used to obtain monoclonal antibodies (MAB) against these compounds by…”
    Get full text
    Journal Article
  18. 18

    Characterization of a new potent, in vivo neutralizing monoclonal antibody to human vascular endothelial growth factor by SCHLAEPPI, J.-M, SIEMEISTER, G, WEINDEL, K, SCHNELL, C, WOOD, J

    “…Vascular endothelial growth factor (VEGF) is an important mediator of tumor-induced angiogenesis and represents a potential target for anticancer therapy…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis by Viloria-Petit, A, Crombet, T, Jothy, S, Hicklin, D, Bohlen, P, Schlaeppi, J M, Rak, J, Kerbel, R S

    Published in Cancer research (Chicago, Ill.) (01-07-2001)
    “…Inhibitors of epidermal growth factor receptor (EGFR) signaling are among the novel drugs showing great promise for cancer treatment in the clinic. However,…”
    Get full text
    Journal Article